U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842589) titled 'Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients with MDR-SRNS' on Jan. 22.
Brief Summary: This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of patients with Multi-drug resistant SRNS
Study Start Date: Feb. 14
Study Type: INTERVENTIONAL
Condition:
Multi-Drug Resistant Nephrotic Syndrome
CAR-T Cell Therapy
Intervention:
BIOLOGICAL: anti-CD19 CAR-T cells
Three dose groups (0.3x105/kg, 1x105/kg, 3x105/kg) were set up, starting from the low dose group climbing to explore the safe and effective dose.
Recruitment Status: RECRUITING...